THE TRAN: Open Payments
NPI 1275199002 · FLOWER MOUND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,873 in 195 payments from 25 companies in 2025. Trend: 2023 $1,769 · 2024 $2,786 · 2025 $3,873
Food & beverage: $3,732Education: $141
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 43 | $900 |
| ABBVIE INC. | 18 | $503 |
| Incyte Corporation | 14 | $307 |
| Janssen Biotech, Inc. | 14 | $277 |
| Amgen Inc. | 15 | $270 |
| UCB, Inc. | 6 | $259 |
| LEO Pharma Inc. | 8 | $219 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $200 |
| Botanix SB Inc | 17 | $140 |
| Arcutis Biotherapeutics, Inc. | 12 | $138 |
Products named: NEMLUVIO, OPZELURA, TREMFYA, OTEZLA, Bimzelx, RINVOQ, SOFDRA, Zoryve.
Industry payments across TX — which companies pay providers there.
